Clinical Research Study for Cataract Surgery
We will soon begin to enroll participants in the CPH-50601 study, which is evaluating an investigational viscoelastic gel (NuVisc Pro) compared with a standard treatment (Amvisc Plus) used during cataract surgery.
About the Study
- The study will last about 22 weeks.
- The goal is to assess the safety and effectiveness of NuVisc Pro during cataract surgery.
Who Can Join?
This study may be a fit if you:
- Are 22 years of age or older
- Have been cleared for cataract surgery in at least one eye
- Have a corrected distance visual acuity (CDVA) that meets study requirements
Why Participate?
By joining, you may have access to an investigational product while undergoing your cataract surgery, and you’ll be contributing to research that may improve surgical outcomes for future patients.
If you are planning cataract surgery and would like to learn more about this study, please contact our research team to see if you may qualify.
Interested? Contact Our Research Team
Glaucoma and Ocular Hypertension
-
Stent for the treatment of Primary Open Angle Glaucoma at the time of cataract surgery
Study description on clinicaltrials.gov
Diabetic Retinopathy
-
Oral medication for patients with moderate to severe Diabetic Retinopathy.
Study description on clinicaltrials.gov
Age Related Macular Degeneration
- Epidemiological study of AMD progression (non-interventional)
Pediatric
-
Dextenza for Inflammation and Pain Following Surgery for Pediatric Cataract.
Study description on clinicaltrials.gov
Past Clinical Trials
Eye Center of Northern Colorado is privileged to have worked with many drugs and devices that went on to gain FDA approval and are now used to treat patients every day. Some of these technologies include:
Cataract
- Acrysof Restor IOL
- Acrysof High Toric IOL
- IQ Vivity IOL
- IC-8 IOL
Glaucoma
- Glaukos iStent
- Xen Shunt
- Glaukos iStent Inject
- Glaukos G2-W
- Hydrus Microstent
- Rhopressa
- Simbrinza
- Glaukos iDose TR
- Elios System to Reduce Intraocular Pressure in Combination with Cataract Surgery
Myopia
- Pediatric Myopia Ophthalmic Solution SYD-101
- Progression of Myopia in Pediatric Patients using Atropine Sulphate 0.01% (OT-101)
Presbyopia
- Kamra Inlay
Retina
- Susvimo for Wet Age-related Macular Degeneration
- Diabetic Retinopathy OPL-0401
- Macular Edima Port Delivery System with Lucentis (Pagoda)
- Wet AMD Port Delivery System with Lucentis (Portal)
Dry Eye
- Tyrvaya Nasal Spray
Keratoconus
- Oxygen Enriched Cross-Linking
Inflammation
- Inveltys
- TobraDex
- Nevanac
